Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Convertible Debt (2015 - 2016)

Updated

Aytu Biopharma (AYTU) posted Convertible Debt of $9,797 for fiscal Q3 2016 (quarter ended Mar 31, 2016), down 99.8% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Convertible Debt (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 9,797.00
Dec 31, 2015 4.92 Mn
Sep 30, 2015 4.83 Mn
API Access

Aytu Biopharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY